Valued at $600.5M at its later-stage round, Apr 2026. Nothing has traded since.
- ·The complete investor list: 19 names
- ·Watch Click Therapeutics: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Click Therapeutics funding history
9 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Mar 2025 | Early Stage VC | $48.6M | ▮ | ▮ |
| Aug 2024 | Debt | $8.3M | ▮ | ▮ |
| May 2024 | Seed Round | $3.0M | ▮ | ▮ |
| Oct 2021 | Later Stage VC | $52.1M | ▮ | ▮ |
| Jun 2018 | Early Stage VC | $17.3M | ▮ | ▮ |
| Apr 2017 | Seed Round | $3.7M | ▮ | ▮ |
| + 3 earlier rounds · a free account shows the full history | ||||
Membership and data by Private Market View
Click Therapeutics valuation
Click Therapeutics was valued at $601 million at its later-stage round in Apr 2026. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Click Therapeutics raised?
Click Therapeutics has raised $268 million across 9 recorded rounds since 2014. The largest was an $8.3 million debt round in Aug 2024; the most recent was a $48.6 million early-stage round in Mar 2025.
Click Therapeutics has filed 9 Form Ds with the SEC since 2014, most recently in Apr 2025 ($48.6 million sold to 3 investors).
How Click Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Click Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →
Frequently asked about Click Therapeutics
- What is Click Therapeutics worth?
- Click Therapeutics is valued at $600.5M as of Oct 2026. Valued at $600.5M at its later-stage round, Apr 2026. Nothing has traded since.
- How much has Click Therapeutics raised?
- Click Therapeutics has raised $268.4M in total funding across 9 recorded rounds.
- When did Click Therapeutics last raise?
- Click Therapeutics last raised in Mar 2025 (Early Stage VC), raising $48.6M.